OLINIS 150IU injection

FOLINIS 150IU injection contains the active ingredient menotropin, which is a medication used in assisted reproductive technology (ART) procedures to stimulate the development of multiple follicles in the ovaries. Menotropin is a purified form of human follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from the urine of postmenopausal women. It works by promoting the growth and maturation of ovarian follicles, which contain the eggs, and helps regulate ovulation.

Key Features:

• Fertility Treatment: FOLINIS 150IU injection is indicated for the treatment of infertility in women who have not ovulated or who have irregular ovulation cycles. It is used in conjunction with other fertility medications as part of controlled ovarian stimulation (COS) protocols in ART procedures such as in vitro fertilization (IVF) and intrauterine insemination (IUI).
• Menotropin: The active ingredient, menotropin, contains both FSH and LH components, which mimic the natural hormones involved in the menstrual cycle. FSH stimulates the growth and development of ovarian follicles, while LH triggers ovulation and promotes the release of mature eggs from the follicles.
• Ovarian Stimulation: FOLINIS 150IU injection is administered subcutaneously or intramuscularly to stimulate the ovaries to produce multiple mature follicles containing eggs. This helps increase the chances of successful fertilization and pregnancy in women undergoing fertility treatment.
• Individualized Dosage: The dosage of FOLINIS 150IU injection is individualized based on the patient’s age, ovarian reserve, response to previous treatments, and other factors. Treatment is typically initiated at a low dose and adjusted according to ovarian response monitored through ultrasound and hormonal assessments.

Uses:

FOLINIS 150IU injection is used for the treatment of infertility in women caused by anovulation or irregular ovulation cycles. It is indicated for use in controlled ovarian stimulation protocols in conjunction with other fertility medications to improve the chances of successful conception and pregnancy in ART procedures.

Dosage and Administration:

• The dosage of FOLINIS 150IU injection is individualized based on the patient’s age, ovarian reserve, response to previous treatments, and other factors.
• Treatment is typically initiated at a low dose (e.g., 75-150IU daily) and adjusted according to ovarian response monitored through ultrasound and hormonal assessments.
• FOLINIS 150IU injection is administered subcutaneously or intramuscularly by a healthcare provider, following proper aseptic technique and injection site rotation.

Precautions:

• Before initiating treatment with FOLINIS 150IU injection, patients should undergo a thorough evaluation to assess ovarian reserve, hormonal status, and other fertility factors.
• Patients should be monitored closely during treatment with FOLINIS 150IU injection for signs of ovarian hyperstimulation syndrome (OHSS), ovarian cysts, and multiple pregnancies.
• Use of FOLINIS 150IU injection may increase the risk of multiple gestation pregnancies, which can pose maternal and fetal health risks. Patients should be counseled about the risks and benefits of treatment.
• FOLINIS 150IU injection should not be used in women with primary ovarian failure or uncontrolled thyroid or adrenal dysfunction.

Side Effects:

Common side effects of FOLINIS 150IU injection may include injection site reactions, abdominal discomfort, bloating, breast tenderness, and mood swings. More serious side effects may include ovarian hyperstimulation syndrome (OHSS), ovarian torsion, and multiple gestation pregnancies.

Frequently Asked Questions (FAQs):

1. How is FOLINIS 150IU injection administered? FOLINIS 150IU injection is administered subcutaneously or intramuscularly by a healthcare provider. The injection site may vary, and proper aseptic technique and rotation of injection sites should be observed.
2. How long does treatment with FOLINIS 150IU injection last? The duration of treatment with FOLINIS 150IU injection may vary depending on individual response to therapy, ovarian reserve, and other factors. Treatment may be continued for several days to weeks as part of controlled ovarian stimulation protocols.
3. What should I do if I miss a dose of FOLINIS 150IU injection? If a dose of FOLINIS 150IU injection is missed, it should be administered as soon as possible. However, if it is almost time for the next dose, the missed dose should